• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·GANX
Held by 2 Gurus
Share

Gain Therapeutics, Inc. Stocks

$ 1.41Last Updated 13.10.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 67.82M

In Guru Portfolios

David Einhorn

Portfolio Weight (%)

0.0%

Change

-0.01%

Fund

Greenlight Capital

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
David EinhornGreenlight Capital0.0%-0.01%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Trending

14.10.2026 21:34

Vimeo's stock soared 55% after Berkshire increased its stake in the company

14.10.2026 21:00

Assets under management at BlackRock reached half of U.S. GDP after rising 15%

14.10.2026 19:52

The dollar hit a new high in nearly a year and a half on the back of U.S. inflation data

14.10.2026 18:42

"Bad News for the Fed": New Inflation Data Sent U.S. Stock and Bond Markets Plummeting

14.10.2026 18:00

Elon Musk praised Micron, a manufacturer of AI memory chips. Should you buy its stock?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026